ENvue Medical, Inc. Announces 1-for-12 Reverse Stock Split
ENvue Medical announced a 1-for-12 reverse stock split effective September 1, 2026, to maintain compliance with Nasdaq Capital Market listing standards. The consolidation will reduce the number of outstanding common shares from approximately 11.1 million to roughly 923,718, while authorized shares remain unchanged at 40 million.
Key figures
- Authorized shares
- 40000000
- Reverse split ratio
- 1-for-12
- Shares outstanding pre split
- 11084616
- Shares outstanding post split
- 923718
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.